Primary and secondary prevention of cardiovascular diseases - metabolic aspects
Schlierf, G.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 546-550
1980
ISSN/ISBN: 0070-4067 PMID: 7223043 Document Number: 156719
Document emailed within 1 workday
Related Documents
Chazov, E.I. 2002: Problems in primary and secondary prevention of cardiovascular diseases Terapevticheskii Arkhiv 74(9): 5-8Tkacheva, O.N.; Sharashkina, N.V. 2010: Possibilities of ramipril in primary and secondary prevention of cardiovascular diseases Kardiologiia 50(8): 63-66
Pavić, J.; Zupanić, M.; Milanović, S.Musić.; Fister, K. 2009: Primary and secondary prevention of cardiovascular diseases embedded in the visiting nurse services: description of the intervention model Collegium Antropologicum 33 Suppl. 1: 81-86
García-Palmieri, M.R. 2000: Primary and secondary prevention of cardiovascular disease in the elderly Boletin de la Asociacion Medica de Puerto Rico 92(1-3): 3-8
Richard, J.L.; Delahaye, F. 1998: Cardiovascular prevention, primary or secondary, in high risk patients Archives des Maladies du Coeur et des Vaisseaux 91(12): 1495-1502
Klomp, C.M.C.; ten Cate, H.; Stehouwer, C.D.A.; Schaper, N.C. 2009: Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events Nederlands Tijdschrift Voor Geneeskunde 153: A109
Almazov, V.A.; Bondarenko, B.B.; Poliakov, I.V.; Chavpetsov, A.F.; Chireĭkin, L.V. 1987: Organizational aspects of the prevention and treatment of cardiovascular diseases Sovetskoe Zdravookhranenie 1987(12): 35-39
Putov, N.V.; Bogdanov, N.A.; Tsiura, I.G.; Poliakov, V.V.; Tyshetskiĭ, V.I. 1982: Principles of the primary and secondary prevention of nonspecific lung diseases Sovetskoe Zdravookhranenie 1982(8): 24-30
Purmová, J.; Opletal, L. 1995: Phytotherapeutic aspects of diseases of the cardiovascular system. 5. Saponins and possibilities of their use in prevention and therapy Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 44(5): 246-251
Maciá Bobes, C.; Ronzón Fernández, Aánzazu.; Fernández García, E. 2007: Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA? Atencion Primaria 39(3): 163-164
Metelitsa, V.I.; Ostrovskaia, T.P.; Duda, S.G.; Filatova, N.P.; Vygodin, V.A.; Mukhamedzhanova, G.F. 1994: The basic antihypertensive drugs for the long-term secondary prevention of cardiovascular diseases (the working group of the multicenter study Captopril and the Quality of Life) Terapevticheskii Arkhiv 66(9): 78-82
Zhdan, V.M.; Holovanova, I.A.; Filatova, V.L.; Khorosh, M.V. 2017: Medical evaluation of efficiency of optimized models for early detection and primary prevention of cardiovascular diseases Wiadomosci Lekarskie 70(3 Pt 1): 433-438
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Grundy, S., M.; Balady, G., J.; Criqui, M., H.; Fletcher, G.; Greenland, P.; Hiratzka, L., F.; Houston-Miller, N.; Kris-Etherton, P.; Krumholz, H., M.; Larosa, J.; Ockene, I., S.; Pearson, T., A.; Reed, J.; Washington, R.; Smith, S., C.,. Jr.; 1997: Guide to primary prevention of cardiovascular diseases: A statement for healthcare professionals from the Task Force on Risk Reduction Circulation 95(9): 2329-2331
Rywik, S. 1977: Course: Lipoprotein metabolism--physiological and clinical aspects. Role of cholesterol and triglyceride determination in the prevention of metabolic diseases and the control of preventive measures Przeglad Lekarski 34(3): 369-370
Beermann, Börn. 2006: Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty Lakartidningen 103(47): 3731-3732
Nordt, T. 2001: Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project Der Internist 42(12): 1705-1707
Makar, O.; Siabrenko, G. 2018: Influence of Physical Activity on Cardiovascular System and Prevention of Cardiovascular Diseases (Review) Georgian Medical News 2018(285): 69-74
Chopeĭ, I.V.; Rosul, M.M.; Hechko, M.M.; Chubirko, K.I.; Korabel'shchykova, M.O.; Ivan'o, N.V. 2014: Cardiovascular continuum: the role of the family doctor in prevention of cardiovascular diseases Wiadomosci Lekarskie 67(2 Pt 2): 243-247
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6